Prevention and Treatment of Osteoporosis in Postmenopausal Women: Defining the Role of Alendronate

By Keam S.J.   Plosker G.L.  

Disease Management & Health Outcomes, Vol. 12, Iss. 1, 2004-01 ,pp. : 19-37

Adis International

Access to resources Recommend Favorite

A Review of the Cost Effectiveness of Bisphosphonates in the Treatment of Post-Menopausal Osteoporosis in Switzerland

By Lippuner Kurt  

Applied Health Economics and Health Policy, Vol. 9, Iss. 6, 2011-11 ,pp. : 403-417

Adis International

Access to resources Recommend Favorite

Management of Postmenopausal Osteoporosis: Defining the Role of Raloxifene

By Wellington K.   Plosker G.L.  

Disease Management & Health Outcomes, Vol. 11, Iss. 10, 2003-01 ,pp. : 673-692

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Ultrasound and Bone Densitometry for Osteoporosis Screening in Post-Menopausal Women

By Mueller Dirk   Gandjour Afschin  

Applied Health Economics and Health Policy, Vol. 6, Iss. 2-3, 2008-01 ,pp. : 113-135

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Secondary vs Tertiary Prevention for Post-Menopausal Osteoporosis

By Mueller Dirk  

Applied Health Economics and Health Policy, Vol. 9, Iss. 4, 2011-07 ,pp. : 259-273

Adis International

Access to resources Recommend Favorite